SNG.L Gross Margin

The Gross Margin of Synairgen PLC (SNG.L) is 68.75%.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

SNG.L Gross Margin - Historical Value

Date	Value
2022-12-31	68.75%

SNG.L Gross Margin - Peers Comparison

Ticker	Name	Value
ADAP	Adaptimmune Therapeutics PLC	99.96%
IVA.PA	Inventiva SA	146.31%
ORPHA.CO	Orphazyme A/S	7775.20%
NANOV.OL	Nordic Nanovector ASA	7775.20%
GNS.L	Genus PLC	36.68%
HPHA.DE	Heidelberg Pharma AG	74.01%
MAB.WA	Mabion SA	75.54%
MYOV	Myovant Sciences Ltd	77.68%
VVY.AS	Vivoryon Therapeutics NV	85.42%
ABC.L	Abcam PLC	71.12%
BGBIO.OL	Bergenbio ASA	100.00%
TILS.L	Tiziana Life Sciences PLC	63.16%
BVXP.L	Bioventix PLC	93.20%
CMPS	Compass Pathways PLC	7775.20%
POXEL.PA	Poxel SA	0.05%
SCLP.L	Scancell Holdings PLC	90.13%
XSPRAY.ST	XSpray Pharma AB (publ)	2539.90%
BCYC	Bicycle Therapeutics PLC	7775.20%
DMYD B.ST	Diamyd Medical AB	-10161.54%
IMCR	Immunocore Holdings PLC	99.12%
NANO.PA	Nanobiotix SA	100.00%
ORY.MC	Oryzon Genomics SA	-4700.00%
SIGHT.PA	Gensight Biologics SA	188.37%
SLN.L	Silence Therapeutics PLC	3133.78%
ALSEN.PA	Sensorion SA	7775.20%
CANTA.ST	Cantargia AB	7775.20%
CNTA	Centessa Pharmaceuticals PLC	7775.20%
IPH.PA	Innate Pharma SA	94.50%
OXB.L	Oxford Biomedica PLC	41.17%
BINV.ST	BioInvent International AB	42.37%
IVACC.ST	Intervacc AB	-29.92%
MOLN.SW	Molecular Partners AG	99.80%
OSE.PA	OSE Immunotherapeutics SA	100.00%
ABVX.PA	Abivax SA	-19700.00%
ALBPS.PA	Biophytis SA	7775.20%
XBRANE.ST	Xbrane Biopharma AB	90.83%